Emergent BioSolutions EBS
NYSE EBS
$6.19 -0.10 (-1.59%)
As of: Oct 21, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026)

Updated

Emergent BioSolutions (EBS) recorded Other Operating Expenses of $305.6 million in Q2 2026, up 267.7% from $83.1 million a year earlier and up 245.3% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026) Analysis & Trends

On a TTM basis, Emergent BioSolutions' Other Operating Expenses came in at $609.7 million as of Jun 30, 2026, up 32.2% year-over-year; for FY2025, it was $403.5 million, down 47.8% from FY2024.

  • Annual Other Operating Expenses has a five-year compound annual growth rate of -7.5% (FY2020 to FY2025).
  • Across earlier years, Other Operating Expenses came in at $773.6 million in FY2024 (-40.3%), $1.3 billion in FY2023 (+70.6%), $759.7 million in FY2022 (-10.4%) and $848.3 million in FY2021 (+42.1%).
  • The Q2 2026 figure is the highest quarterly Other Operating Expenses since Q2 2024.
  • On a year-over-year basis, Other Operating Expenses rose in 1 of the last eight quarters, with an average year-over-year change of 0.0%.
  • Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 267.7% in Q2 2026, against a decline of 75.5% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $88.5 million (Q1 2026), $113.4 million (Q4 2025) and $102.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Emergent BioSolutions 319.40 Mn -431.50 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 305.60 Mn
Mar 31, 2026 88.50 Mn
Dec 31, 2025 113.40 Mn
Sep 30, 2025 102.20 Mn
Jun 30, 2025 83.10 Mn
Mar 31, 2025 104.80 Mn
Dec 31, 2024 134.30 Mn
Sep 30, 2024 138.90 Mn
Jun 30, 2024 339.60 Mn
Mar 31, 2024 160.80 Mn
Dec 31, 2023 201.30 Mn
Sep 30, 2023 411.30 Mn
Jun 30, 2023 513.40 Mn
Mar 31, 2023 169.90 Mn
Dec 31, 2022 245.10 Mn
Sep 30, 2022 161.20 Mn
Jun 30, 2022 183.80 Mn
Mar 31, 2022 169.90 Mn
Dec 31, 2021 259.20 Mn
Sep 30, 2021 232.00 Mn
API Access

Emergent BioSolutions Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY